395 related articles for article (PubMed ID: 16718381)
1. Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers.
Dinesh KP; Devaraj H; Murugan V; Rajaraman R; Niranjali S
Mol Cell Biochem; 2006 Jul; 287(1-2):177-83. PubMed ID: 16718381
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
[TBL] [Abstract][Full Text] [Related]
3. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene.
Rio PG; Maurizis JC; Peffault de Latour M; Bignon YJ; Bernard-Gallon DJ
Int J Cancer; 1999 Mar; 80(6):823-6. PubMed ID: 10074913
[TBL] [Abstract][Full Text] [Related]
4. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
Rhiem K; Todt U; Wappenschmidt B; Klein A; Wardelmann E; Schmutzler RK
Anticancer Res; 2010 Sep; 30(9):3445-9. PubMed ID: 20944121
[TBL] [Abstract][Full Text] [Related]
5. [BRCA1 protein expression in sporadic breast and its clinical significance].
Wang BZ; Wang J; Wu Q
Zhonghua Wai Ke Za Zhi; 2003 Mar; 41(3):186-8. PubMed ID: 12887776
[TBL] [Abstract][Full Text] [Related]
6. Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability.
Vaurs-Barriere C; Vidal V; Penault-Llorca F; Kwiatkowski F; Maugard C; Bignon Y
Int J Oncol; 1998 Jun; 12(6):1373-8. PubMed ID: 9592202
[TBL] [Abstract][Full Text] [Related]
7. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
Okada S; Tokunaga E; Kitao H; Akiyoshi S; Yamashita N; Saeki H; Oki E; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 May; 19(5):1499-507. PubMed ID: 22179631
[TBL] [Abstract][Full Text] [Related]
9. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer.
Charef-Hamza S; Trimeche M; Ziadi S; Amara K; Gaddas N; Mokni M; Sriha B; Yacoubi T; Korbi S
Cancer Lett; 2005 Jun; 224(2):185-91. PubMed ID: 15914269
[TBL] [Abstract][Full Text] [Related]
11. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
[TBL] [Abstract][Full Text] [Related]
12. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
13. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
14. Regulation of BRCA1 expression and its relationship to sporadic breast cancer.
Mueller CR; Roskelley CD
Breast Cancer Res; 2003; 5(1):45-52. PubMed ID: 12559046
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
16. Analysis of BRCA1 involvement in breast cancer in Indian women.
Pestonjamasp PH; Mittra I
J Biosci; 2000 Mar; 25(1):19-23. PubMed ID: 10824194
[TBL] [Abstract][Full Text] [Related]
17. Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer.
Rouba A; Kaisi N; Al-Chaty E; Badin R; Pals G; Young C; Worsham MJ
Int J Mol Med; 2000 Nov; 6(5):565-9. PubMed ID: 11029525
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer.
Niederacher D; An HX; Camrath S; Dominik SI; Göhring UJ; Oertel A; Grass M; Hantschmann P; Lordnejad MR; Beckmann MW
Eur J Cancer; 1998 Oct; 34(11):1770-6. PubMed ID: 9893667
[TBL] [Abstract][Full Text] [Related]
19. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
20. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]